Aster DM Healthcare Buys ₹5.80 Cr Stake in Oyster Green for Solar Power

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Aster DM Healthcare Buys ₹5.80 Cr Stake in Oyster Green for Solar Power
Overview

Aster DM Healthcare has finalized its acquisition of a 26% stake in Oyster Green Hybrid Two Private Limited for a revised ₹5.80 crore. This strategic move supports the company's renewable energy objectives, enabling the establishment of a captive solar power plant to meet electricity needs and reduce its carbon footprint.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Aster DM Healthcare Completes Acquisition for Renewable Energy Project

Aster DM Healthcare Group has completed its acquisition of a 26% stake in Oyster Green Hybrid Two Private Limited for ₹5.80 crore. The group finalized the investment for this equity share, a strategic move to secure renewable energy for its operations.

Key Financials and Payment Details

The total acquisition cost was revised to ₹5.80 crore (₹580.00 lakh), a reduction from the initially agreed ₹7 crore. The final investment payment was made in two tranches: ₹3.54 crore on October 2, 2025, and ₹2.26 crore on April 22, 2026.

As of March 31, 2025, Oyster Green Hybrid Two Private Limited reported a paid-up capital of ₹10.00 crore and a net worth of ₹9.74 crore. The entity recorded a Net Profit After Tax of (₹5.43 lakh) for the financial year ended March 31, 2025.

Strategic Importance for Sustainability

This investment is a key part of Aster DM Healthcare's strategy to adopt renewable energy and reduce its environmental impact. The acquisition enables the establishment of a captive solar power plant to meet a portion of the company's electricity needs.

The agreement ensures Aster DM Healthcare will purchase 100% of the net electricity output from the 18 MWp solar power plant developed by Oyster. This initiative aims to lower the group's carbon footprint and reduce operational costs through clean energy sourcing.

Background and Negotiations

Aster DM Healthcare has been pursuing sustainability goals, including past announcements and commissioning of solar projects like an 8.5 MW facility in Kerala. This acquisition aligns with its broader ESG commitments. The initial agreement for this stake was announced with a higher price, indicating a successful negotiation for a reduced final transaction value.

Changes and Expected Benefits

Following this acquisition, Aster DM Healthcare will have a dedicated source of renewable energy for its facilities. Oyster Green will construct, operate, and maintain the 18 MWp solar power plant for Aster. The company anticipates achieving cost savings on electricity consumption over the long term and reinforces its position as an ESG-conscious healthcare provider.

Potential Risks

Investors should monitor the profitability of Oyster Green Hybrid Two Private Limited, given its net loss of ₹5.43 lakh in FY25. The operational performance and maintenance of the 18 MWp solar power plant are crucial for realizing the expected benefits. Additionally, the company reported a past minor insider trading code violation by an employee in March 2025.

What to Track Next

  • The operational efficiency and energy generation from the new solar power plant.
  • Actual cost savings realized from renewable energy procurement.
  • Aster DM Healthcare's future investments and targets related to renewable energy and sustainability.
  • Updates on Oyster Green Hybrid Two Private Limited's financial performance.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.